Document is current
Any future updates will be listed below
-
Authors
Golmohammadi, Mahtab
Sheikhha, Mohammad Hasan
Ganji, Fatemeh
Shirani, Ali
Barati, Mahmood
Kalantar, Seyed Mehdi
Haramshahi, Seyed Mohammad Amin
Karkuki Osguei, Nushin
Samadikuchaksaraei, Ali https://orcid.org/0000-0002-2108-9927
-
Funding
Funding for this research was provided by:
Iran University of Medical Sciences (98-04-14-16074)
Iranian Council for Development of Stem Cell Sciences and Technologies (11/79319)
- License Information
-
More Information
Article History
Received: 31 August 2024
Accepted: 20 February 2025
First Online: 21 February 2025
Declarations
:
: Samadikuchaksaraei is shareholder and CEO of Baztarmim Company, which is focused on production of tissue engineering products. Other authors have no conflicts of interest to declare.
: The study was approved by the Ethical Committees of the Iranian Ministry of Health (code: EC-00264, 17 August 2013), the Iran University of Medical Sciences (IUMS) (code: IR.IUMS.rec.1393.25093, 30 September 2014) and Iranian Academic Center for Education, Culture and Research (code: IR.ACERE.ROYAN.REC.1398.186, 28 October 2019). All fetuses were obtained with written informed consent.
